Suppr超能文献

透析退出的风险因素:1999-2008 年澳大利亚和新西兰透析和移植(ANZDATA)登记处的分析。

Risk factors for dialysis withdrawal: an analysis of the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, 1999-2008.

机构信息

Renal Unit, Queen Elizabeth Hospital, Hong Kong.

出版信息

Clin J Am Soc Nephrol. 2012 May;7(5):775-81. doi: 10.2215/CJN.07420711. Epub 2012 Mar 29.

Abstract

BACKGROUND AND OBJECTIVES

Dialysis withdrawal (DW) in patients with ESRD is increasing in importance. This study assessed causes of death and risk factors for DW in Australia and New Zealand in the first year of dialysis.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This retrospective observational cohort study included all adult Australians and New Zealanders beginning renal replacement therapy in 1999-2008.

RESULTS

A total of 24,884 patients with 10,073 deaths were included. Deaths from cardiac and social causes (predominantly DW) accounted for 38% and 28% of all deaths, respectively. Cumulative incidence of DW was 3.5% at 1 year (95% confidence interval [CI], 3.3%-3.8%), 9.0% at 3 years (95% CI, 8.6%-9.4%), and 13.4% at 5 years (95% CI, 12.8%-13.9%). In multivariate analysis, predictors for DW in the first year were older age (subhazard ratio [SHR], 1.70 per decade [95% CI, 1.59-1.83]; P<0.001), late referral (SHR, 1.83 [95% CI, 1.59-2.11]; P<0.001), comorbid conditions (SHR, 1.33 per each additional comorbid condition [95% CI, 1.25-1.41]; P<0.001), and diabetes (SHR, 1.16 [95% CI, 1.00-1.34]; P=0.05). Negative predictors for DW included male sex (SHR, 0.75 [95% CI, 0.66-0.87]; P<0.001), indigenous ethnicity (SHR, 0.74 [95% CI, 0.58-0.95]; P=0.02), other nonwhite race (SHR, 0.66 [95% CI, 0.48-0.91]; P=0.01), and peritoneal dialysis user (SHR, 0.59 [95% CI, 0.49-0.72]; P<0.001).

CONCLUSIONS

DW is common among dialysis patients in Australia and New Zealand. Risk factors include older age, female sex, white race, diabetes, higher comorbidity burden, hemodialysis user, and late referral to nephrologist.

摘要

背景与目的

终末期肾病(ESRD)患者的透析退出(DW)越来越重要。本研究评估了澳大利亚和新西兰透析开始后第一年的死亡原因和 DW 风险因素。

设计、地点、参与者和测量:这项回顾性观察队列研究包括了 1999-2008 年期间开始肾脏替代治疗的所有澳大利亚和新西兰成年人。

结果

共纳入 24884 例患者,其中 10073 例死亡。心脏和社会原因(主要是 DW)导致的死亡分别占所有死亡的 38%和 28%。DW 的 1 年累积发生率为 3.5%(95%置信区间[CI],3.3%-3.8%),3 年为 9.0%(95% CI,8.6%-9.4%),5 年为 13.4%(95% CI,12.8%-13.9%)。多变量分析显示,DW 的第一年的预测因素包括年龄较大(亚危险比[SHR],每十年增加 1.70[95%CI,1.59-1.83];P<0.001)、晚期转诊(SHR,1.83[95%CI,1.59-2.11];P<0.001)、合并症(SHR,每增加一种合并症增加 1.33[95%CI,1.25-1.41];P<0.001)和糖尿病(SHR,1.16[95%CI,1.00-1.34];P=0.05)。DW 的负预测因素包括男性(SHR,0.75[95%CI,0.66-0.87];P<0.001)、土著民族(SHR,0.74[95%CI,0.58-0.95];P=0.02)、其他非白人种族(SHR,0.66[95%CI,0.48-0.91];P=0.01)和腹膜透析患者(SHR,0.59[95%CI,0.49-0.72];P<0.001)。

结论

DW 在澳大利亚和新西兰的透析患者中很常见。风险因素包括年龄较大、女性、白种人、糖尿病、合并症负担较高、血液透析患者和肾脏科医生的晚期转诊。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验